Side-by-side financials for ENTA and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ENTA | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #49 |
| Revenue (latest FY) | $65.32M | - |
| Net income (latest FY) | -$81.89M | - |
| Net margin | -125.4% | - |
| SEC filings | 822 | 1,004 |
Full pages: ENANTA PHARMACEUTICALS INC and AstraZeneca PLC, or browse the full rankings.